Leucine-enriched Branched-chain Amino Acid on Muscle Thickness, Interleukin-6, SOFA Score in Critical Illness

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 14, 2023

Primary Completion Date

May 10, 2024

Study Completion Date

May 10, 2024

Conditions
Critical IllnessMuscle Wasting
Interventions
DIETARY_SUPPLEMENT

BCAA

"branched-chain amino acid (bcaa) (ratio valine:leucine:isoleucine = 1.2:2:1) 40 g/day (leucine 19 g/day) form: powdered bcaa sealed in 8 g sachet package or bcaa parenteral 250 mL per bag.~frequency: 1 sachet bcaa dissolved in oral nutrition supplement (standard nutrition) 5 times per day, or bcaa parenteral, or combination of bcaa enteral \& parenteral.~duration: 10 days"

OTHER

Standard nutrition

Target energy of 20 kcal/kg BW/day Target protein ratio protein:non-protein calorie 1:70

OTHER

Standard physiotherapy

A symmetric biphasic rectangular pulse was employed, with a frequency of 100 Hz, pulse width of 500 µs, Ton 5 s, Toff 25 s, ramp up of 1 s and ramp down of 1 s.

Trial Locations (2)

10430

Dr. Cipto Mangunkusumo Hospital, Jakarta Pusat

Unknown

Universitas Indonesia Hospital, Depok

All Listed Sponsors
lead

Indonesia University

OTHER

NCT06167772 - Leucine-enriched Branched-chain Amino Acid on Muscle Thickness, Interleukin-6, SOFA Score in Critical Illness | Biotech Hunter | Biotech Hunter